Cytokines and IgE Regulation

  • Juha Punnonen
  • Jan E. de Vries


Synthesis of allergen-specific immunoglobulin E (IgE) in vivo is a result of multiple interactions among B-cells, T-cells, and professional antigen-presenting cells (APC). B-cell activation is initiated when specific B-cells recognize the allergen by cell surface immunoglobulin (sIg). However, costimulatory molecules expressed by activated T cells in both soluble and membrane-bound forms are necessary for differentiation of B-cells into Ig-secreting plasma cells (1). Activation of T helper (Th) cells requires recognition of an antigenic peptide in the context of major histocompatibility complex (MHC) class II molecules on the plasma membrane of APC, such as monocytes, dendritic cells, Langerhans cells, or primed B-cells. Professional APC can efficiently capture the antigen, and the peptide-MHC class II complexes are formed in a post-Golgi, proteolytic intracellular compartment and subsequently exported to the plasma membrane, where they are recognized by T-cell receptor (TCR) (2). In addition, activated B-cells express CD80 (B7-1) and CD86 (B7-2, B70), which are the counter receptors for CD28 and which provide a costimulatory signal for T-cell activation resulting in T-cell proliferation and cytokine synthesis (3). Since allergen-specific T-cells from atopic individuals generally belong to the Th2-cell subset, activation of these cells also leads to production of interleukin (IL)-4 and IL-13, which, together with membrane-bound costimulatory molecules expressed by activated T-helper cells, direct B-cell differentiation into IgE-secreting plasma cells.


Unfractionated Peripheral Blood Mononuclear Cell 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Coffman RL, Lebman DA, Rothman P (1993) Mechanism and regulation of immunoglobulin isotype switching. Adv Immunol 54: 229–270.PubMedCrossRefGoogle Scholar
  2. 2.
    Germain RN (1994) MHC-dependent antigen processing and peptide presentation: providing ligands for T lymphocyte activation. Cell 76: 287–299.PubMedCrossRefGoogle Scholar
  3. 3.
    June CH, Bluestone JA, Nadler LM, Thompson CB (1994) The B7 and CD28 receptor families. Immunol Today 15: 321–331.PubMedCrossRefGoogle Scholar
  4. 4.
    Esser C, Radbruch A (1990) Immunoglobulin class switching: molecular and cellular analysis. Annu Rev Immunol 8: 717–735.PubMedCrossRefGoogle Scholar
  5. 5.
    Kataoka T, Miyata T, Honjo T (1981) Repetitive sequences in class-switch recombination regions of immunoglobulin heavy chain genes. Cell 23: 357–368.PubMedCrossRefGoogle Scholar
  6. 6.
    Yancopoulos G, DePinho R, Zimmerman R, Luzker S, Rosenberg N, Alt FW (1986) Secondary rearrangement events in pre-B cells: VhDJh replacement by a LINE-1 sequence and directed class-switching. EMBO J 5: 3259–3266.PubMedGoogle Scholar
  7. 7.
    Kuhn R, Rajewsky K, Muller W (1991) Generation and analysis of interleukin-4 deficient mice. Science 254: 707–710.PubMedCrossRefGoogle Scholar
  8. 8.
    Itoh N, Yonehara S, Ishii A, Yonehara M, Mizushima S, Sameshima M, Hase A, Seto Y, Nagata S (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66: 233–243.PubMedCrossRefGoogle Scholar
  9. 9.
    Clark EA, Ledbetter JA (1994) How B and T-cells talk to each other. Nature 367: 425–428.PubMedCrossRefGoogle Scholar
  10. 10.
    Aversa G, Punnonen J, Carballido JM, Cocks BG, De Vries JE (1994) CD40 ligand-CD40 interaction in Ig isotype switching in mature and immature human B-cells. Semin Immunol 6: 295–301.PubMedCrossRefGoogle Scholar
  11. 11.
    Clark EA, Ledbetter JA (1986) Activation of human B-cells mediated through two distinct cell surface differentiation antigens, Bp35 and Bp50. Proc Natl Acad Sci USA 83: 4494–4498.PubMedCrossRefGoogle Scholar
  12. 12.
    Jabara HH, Fu SM, Geha RS, Vercelli D (1990) CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B-cells. J Exp Med 172: 1861–1864.PubMedCrossRefGoogle Scholar
  13. 13.
    Gascan H, Gauchat JF, Aversa G, Van Vlasselaer P, de Vries JE (1991) Anti-CD40 monoclonal antibodies or CD4+ T-cell clones and IL-4 induce IgG4 and IgE switching in purified human B-cells via different signaling pathways. J Immunol 147: 8–13.PubMedGoogle Scholar
  14. 14.
    Zhang K, Clark EA, Saxon A (1991) CD40 stimulation provides an IFN-gamma-independent and IL-4dependent differentiation signal directly to human B-cells for IgE production. J Immunol 146: 1836–1842.PubMedGoogle Scholar
  15. 15.
    Banchereau J, de Paoli P, Valle A, Garcia E, Rousset F (1991) Long-term human B-cell lines dependent on interleukin-4 and antibody to CD40. Science 251: 70–72.PubMedCrossRefGoogle Scholar
  16. 16.
    Armitage RJ, Fanslow WC, Strockbine L, Sato TA, Clifford KN, Macduff BM, Anderson DM, Gimpel SD, Davis-Smith T, Maliszewski CR, Clark EA, Smith CA, Grabstein KH, Cosman D, Spriggs MK (1992) Molecular and biological characterization of a murine ligand for CD40. Nature 357: 80–82.PubMedCrossRefGoogle Scholar
  17. 17.
    Hollenbaugh D, Grosmaire LS, Kullas CD, Chalupny NJ, Braesch-Andersen S, Noelle RJ, Stamenkovic I, Ledbetter JA, Aruffo A (1992) The human T-cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B-cell co-stimulatory activity. EMBO J 11: 4313–4321.PubMedGoogle Scholar
  18. 18.
    Cocks BG, de Waal Malefyt R, Galizzi JP, De Vries JE, Aversa G (1993) IL-13 induces proliferation and differentiation of human B-cells activated by the CD40 ligand. Int Immunol 5: 657–663.PubMedCrossRefGoogle Scholar
  19. 19.
    Spriggs MK, Armitage RJ, Strockbine L, Clifford KN, Macduff BM, Sato TA, Maliszewski CR, Fanslow WC (1992) Recombinant human CD40 ligand stimulates B-cell proliferation and immunoglobulin E secretion. J Exp Med 176: 1543–1550.CrossRefGoogle Scholar
  20. 20.
    Durandy A, Schiff C, Bonnefoy JY, Forveille M, Rousset F, Mazzei G, Milili M, Fischer A (1993) Induction by anti-CD40 antibody or soluble CD40 ligand and cytokines of IgG, IgA and IgE production by B-cells from patients with X-linked hyper IgM syndrome. Eur J Immunol 23: 2294–2299.Google Scholar
  21. 21.
    Lane P, Brocker T, Hubele S, Padovan E, Lanzavecchia A, McConnell F (1993) Soluble CD40 ligand can replace the normal T-cell-derived CD40 ligand signal to B-cells in T-cell-dependent activation. J Exp Med 177: 1209–1213.PubMedCrossRefGoogle Scholar
  22. 22.
    Fuleihan R, Ramesh N, Loh R, Jabara H, Rosen RS, Chatila T, Fu SM, Stamenkovic I, Geha RS (1993) Defective expression of the CD40 ligand in X chromosome-linked immunoglobulin deficiency with normal or elevated IgM. Proc Natl Acad Sci USA 90: 2170–2173.PubMedCrossRefGoogle Scholar
  23. 23.
    Di Santo JP, Bonnefoy JY, Gauchat JF, Fischer A, De Saint Basile G (1993) CD40 ligand mutations in x-linked immunodeficiency with hyper-IgM. Nature 361: 541–543.CrossRefGoogle Scholar
  24. 24.
    Allen RC, Armitage RJ, Conley ME, Rosenblatt H, Jenkins NA, Copeland NG, Bedell MA, Edelhoff S, Disteche CM, Simoneaux DK, Fanslow BC, Belmont J, Spriggs MK (1993) CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259: 990–993.PubMedCrossRefGoogle Scholar
  25. 25.
    Aruffo A, Farrington M, Hollenbaugh D, Li X, Milatovich A, Nonoyama S, Bajorath J, Grosmaire LS, Stenkamp R, Neubauer M (1993) The CD40 ligand, gp39, is defective in activated T-cells from patients with X-linked hyper-IgM syndrome. Cell 72: 291–300.PubMedCrossRefGoogle Scholar
  26. 26.
    Farrington M, Grosmaire LS, Nonoyama S, Fischer SH, Hollenbaugh D, Ledbetter JA, Noelle RI, Aruffo A, Ochs HD (1994) CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency. Proc Natl Acad Sci USA 91: 1099–1103.PubMedCrossRefGoogle Scholar
  27. 27.
    Gauchat JF, Henchoz S, Mazzei G, Aubry JP, Brunner T, Blasey H, Life P, Talabot D, Flores-Romo L, Thompson J, Kishi K, Butterfield J, Dahinden C, Boonefoy J-Y (1993) Induction of human IgE synthesis in B-cells by mast cells and basophile. Nature 365: 340–343.PubMedCrossRefGoogle Scholar
  28. 28.
    Burd PR, Thompson WC, Max EE, and Mills FC (1995) Activated mast cells produce interleukin 13. J Exp Med 181: 1373–1380.PubMedCrossRefGoogle Scholar
  29. 29.
    Brown MA, Pierce JH, Watson CJ, Falco J, Ihle JN, Paul WE (1987) B-cell stimulatory factor-1/ interleukin-4 mRNA is expressed by normal and transformed mast cells. Cell 50: 809–818.PubMedCrossRefGoogle Scholar
  30. 30.
    Schmitz J, Thiel A, Kuhn R, Rajewsky K, Muller W, Assenmacher M, Radbruch A (1994) Induction of interleukin 4 (IL-4) expression in T helper (Th) cells is not dependent on IL-4 from non-Th cells. J Exp Med 179: 1349–1353.PubMedCrossRefGoogle Scholar
  31. 31.
    Cayabyab M, Phillips JH, Lanier LL (1994) CD40 preferentially costimulates activation of CD4+ T-lymphocytes. J Immunol 152: 1523–1531.PubMedGoogle Scholar
  32. 32.
    Grewai IS, Xu J, Flavell RA (1995) Impairment of antigen-specific T-cell priming in mice lacking CD40 ligand. Nature 378: 617–620.CrossRefGoogle Scholar
  33. 33.
    van Essen D, Kikutani H, Gray D (1995) CD40 ligand-transduced co-stimulation of T-cells in the development of helper function. Nature 378: 620–623.PubMedCrossRefGoogle Scholar
  34. 34.
    Life P, Gauchat JF, Schnuriger V, Estoppey S, Mazzei G, Durandy A, Fischer A, Bonnefoy JY (1994) T-cell clones from an X-linked hyperimmunoglobulin (IgM) patient induce IgE synthesis in vitro despite expression of nonfunctional CD40 ligand. J Exp Med 180: 1775–1784.PubMedCrossRefGoogle Scholar
  35. 35.
    Rickert RC, Rajewsky K, Roes J (1995) Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 376: 352–355.PubMedCrossRefGoogle Scholar
  36. 36.
    Stamenkovic I, Sgroi D, Aruffo A, Sy MS, Anderson T (1991) The B-lymphocyte adhesion molecule CD22 interacts with leukocyte common antigen CD45RO on T-cells and alpha 2–6 sialyltransferase, CD75, on B-cells. Cell 66: 1133–1144.PubMedCrossRefGoogle Scholar
  37. 37.
    Kapsenberg ML, Jansen HM, Bos JD, Wierenga EA (1992) Role of type 1 and type 2 T helper cells in allergic diseases. Curr Opin Immunol 4: 788–793.PubMedCrossRefGoogle Scholar
  38. 38.
    Romagnani S (1991) Human TH1 and TH2 subsets: doubt no more. Immunol Today 12: 256–257.PubMedCrossRefGoogle Scholar
  39. 39.
    Mosmann TR and Coffman RL (1989) Heterogeneity of cytokine secretion patterns and functions of helper T-cells. Adv Immunol 46: 111–147.PubMedCrossRefGoogle Scholar
  40. 40.
    De Vries JE, Carballido JM, Sornasse T, Yssel H (1995) Antagonizing the differentiation and functions of human T helper type 2 cells. Curr Opin Immunol 7: 771–778.PubMedCrossRefGoogle Scholar
  41. 41.
    Vollenweider S, Saurat JH, Rocken M, Hauser C (1991) Evidence suggesting involvement of interleukin-4 (IL-4) production in spontaneous in vitro IgE synthesis in patients with atopic dermatitis. J Allergy Clin Immunol 87: 1088–1095.PubMedCrossRefGoogle Scholar
  42. 42.
    Saryan JA, Leung DY, Geha RS (1983) Induction of human IgE synthesis by a factor derived from T-cells of patients with hyper-IgE states. J Immunol 130: 242–247.PubMedGoogle Scholar
  43. 43.
    Del Prete G, Maggi E, Parronchi P, Chretien I, Tiri A, Macchia D, Ricci M, Banchereau J, de Vries J, Romagnani S (1988) IL-4 is an essential factor for the IgE synthesis induced in vitro by human T-cell clones and their supernatants. J Immunol 140: 4193–4198.PubMedGoogle Scholar
  44. 44.
    Rousset F, Robert J, Andary M, Bonnin JP, Souillet G, Chretien I, Briere F, Pene J, De Vries JE (1991) Shifts in interleukin-4 and interferon-gamma production by T-cells of patients with elevated serum IgE levels and the modulatory effects of these lymphokines on spontaneous IgE synthesis. J Allergy Clin Immunol 87: 58–69.PubMedCrossRefGoogle Scholar
  45. 45.
    Robinson DS, Hamid Q, Ying S, Tsicopoulos A, Barkans J, Bentley AM, Corrigan C, Durham SR, Kay AB (1992) Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Engl J Med 326: 298–304.PubMedCrossRefGoogle Scholar
  46. 46.
    Huang S-K, Xiao H-Q, Kleine-Tebbe J, Paciotti G, Marsh DG, Lichtenstein LM, Liu MC (1995) IL-13 expression at the sites of allergen challenge in patients with asthma. J Immunol 155: 2688–2694.PubMedGoogle Scholar
  47. 47.
    Wierenga EA, Snoek M, de Groot C, Chretien I, Bos JD, Jansen HM, Kapsenberg ML (1990) Evidence for compartmentalization of functional subsets of CDT“ T-lymphocytes in atopic patients. J Immunol 144: 4651–4656.PubMedGoogle Scholar
  48. 48.
    Parronchi P, Macchia D, Piccinni MP, Biswas P, Simonelli C, Maggi E, Ricci M, Ansari AA, Romagnani S (1991) Allergen-and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production. Proc Natl Acad Sci USA 88: 4538–4542.PubMedCrossRefGoogle Scholar
  49. 49.
    Yssel H, Johnson KE, Schneider PV, Wideman J, Ten A, Kastelein R, De Vries JE (1992) T-cell activation-inducing epitopes of the house dust mite allergen Der p I. Proliferation and lymphokine production patterns by Der p I-specific CD4+ T-cell clones. J Immunol 148: 738–745.PubMedGoogle Scholar
  50. 50.
    van der Ploeg I, Scheynius A, Tengvall Linder M, Hagermark O, Wahlgren CF (1995) Elevated gene expression for interleukin-13 in the skin of atopic dermatitis patients (abstract). In: The 9th International Congress of Immunology, San Francisco, July 23–29.Google Scholar
  51. 51.
    Kay AB, Ying S, Varney V, Gaga M, Durham SR, Moqbel R, Wardlaw AJ, Hamid Q (1991) Messenger RNA expression of the cytokine gene cluster, interleukin 3 (IL-3), IL-4, IL-5, and granulocyte/ macrophage colony-stimulating factor, in allergen-induced late-phase cutaneous reactions in atopic subjects. J Exp Med 173: 775–778.PubMedCrossRefGoogle Scholar
  52. 52.
    Marsh DG, Neely JD, Breazeale DR, Ghosh B, Freidhoff LR, Ehrlich-Kautzky E, Schou C, Krishnaswamy G, Beaty TH (1994) Linkage analysis of 1L4 and other chromosome 5g31.1 markers and total serum immunoglobulin E concentrations. Science 264: 1152–1156.Google Scholar
  53. 53.
    Howard MC, Miyajima A, Coffman R (1993) T-cell derived cytokines and their receptors. In: Paul WE, ed. Fundamental Immunology. Raven, New York, pp. 763–800.Google Scholar
  54. 54.
    Tepper RI, Pattengale PK, Leder P (1989) Murine interleukin-4 displays potent anti-tumor activity in vivo. Cell 57: 503–512.PubMedCrossRefGoogle Scholar
  55. 55.
    Chatelain R, Varkila K, Coffman RL (1992) IL-4 induces a Th2 response in Leishmania major-infected mice. J Immunol 148: 1182–1187.PubMedGoogle Scholar
  56. 56.
    Somasse T, Larenas PV, Davis KA, deVries JE, Yssel H (1996) Differentiation and stability of T helper 1 and 2 cells derived from naive human neonatal CD4+ T cells analyzed at single cell level. J Exp Med 184: 473–483.CrossRefGoogle Scholar
  57. 57.
    Kopf M, Le Gros G, Bachmann M, Lamers MC, Bluethmann H, Kohler G (1993) Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362: 245–248.PubMedCrossRefGoogle Scholar
  58. 58.
    Kopf M, Le Gros G, Coyle AJ, Kosco-Vilbois M, Brombacher F (1995) Immune responses of IL-4, IL-5, IL-6 deficient mice. Immunol Rev 148: 45–69.PubMedCrossRefGoogle Scholar
  59. 59.
    Coffman RL, Seymour BW, Hudak S, Jackson J, Rennick D (1989) Antibody to interleukin-5 inhibits helminth-induced eosinophilia in mice. Science 245: 308–310.PubMedCrossRefGoogle Scholar
  60. 60.
    Foster PS, Hogan SP, Ramsay AJ, Matthaei KI, Young IG (1996) Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model. J Exp Med 183: 195–201.PubMedCrossRefGoogle Scholar
  61. 61.
    Kopf M, Brombacher F, Hodgkin PD, Ramsay AJ, Milboume EA, Dai WJ, Ovington KS, Behm CA, Kohler G, Young IG, Matthaei KI (1996) IL-5-deficient mice have a developmental defect in CDS+ B-1 cells and lack eosinophilia but have normal antibody and cytotoxic T-cell responses. Immunity 4: 15–24.PubMedCrossRefGoogle Scholar
  62. 62.
    Ehlers S, Smith KA (1991) Differentiation of T-cell lymphokine gene expression: the in vitro acquisition of T-cell memory. J Exp Med 173: 25–36.PubMedCrossRefGoogle Scholar
  63. 63.
    Brinkmann V, Kristofic C (1995) TCR-stimulated naive human CD4+ 45R0- T-cells develop into effector cells that secrete IL-13, IL-5, and IFN-gamma, but no IL-4, and help efficient IgE production by B-cells. J Immunol 154: 3078–3087.PubMedGoogle Scholar
  64. 64.
    Jung T, Wijdenes J, Neumann C, de Vries JE, Yssel H (1996) Interleukin-13 is produced by activated human CD45RA+ and CD45RO+ T-cells: modulation by interleukin-4 and interleukin-12. Eur J Immunol 26: 571–577.PubMedCrossRefGoogle Scholar
  65. 65.
    Yoshimoto T, Bendelac A, Hu-Li J, Paul WE (1995) Defective IgE production by SJL mice is linked to the absence of CD4+, NK1.1+ T-cells that promptly produce interleukin 4. Proc Natl Acad Sci USA 92:11, 931–11, 934.Google Scholar
  66. 66.
    Yoshimoto T, Bendelac A, Watson C, Hu-Li J, Paul WE (1995) Role of NK1.1+ T-cells in a Th2 response and in immunoglobulin E production. Science 270: 1845–1847.Google Scholar
  67. 67.
    Yang LP, Byun DG, Demeure CE, Vezzio N, Delespesse G (1995) Default development of cloned human naive CD4 T-cells into interleukin-4- and interleukin-5-producing effector cells. Eur J Immunol 25: 3517–3520.PubMedCrossRefGoogle Scholar
  68. 68.
    McKenzie AN, Culpepper JA, de Waal Malefyt R, Briere F, Punnonen J, Aversa G, Sato A, Dang W, Cocks BG, Menon S, de Vries JE, Banchereau J, Zurawski G (1993) Interleukin 13, a T-cell-derived cytokine that regulates human monocyte and B-cell function. Proc Natl Acad Sci USA 90: 3735–3739.PubMedCrossRefGoogle Scholar
  69. 69.
    Minty A, Chalon P, Derocq JM, Dumont X, Guillemot JC, Kaghad M, Labit C, Leplatois P, Liauzun P, Miloux B, Minty C, Casellas P, Loison G, Lupker J, Shire D, Ferrara P, Caput D (1993) Interleukin-13 is a new human lymphokine regulating inflammatory and immune responses. Nature 362: 248–250.PubMedCrossRefGoogle Scholar
  70. 70.
    Lakkis FG, Cruet EN (1993) Cloning of rat interleukin-13 (IL-13) cDNA and analysis of IL-13 gene expression in experimental glomerulonephritis. Biochem Biophys Res Commun 197: 612–618.PubMedCrossRefGoogle Scholar
  71. 71.
    Zurawski SM, Vega F Jr, Huyghe B, Zurawski G (1993) Receptors for interleukin-13 and interleukin-4 are complex and share a novel component that functions in signal transduction. EMBO J 12: 2663–2670.PubMedGoogle Scholar
  72. 72.
    McKenzie AN, Li X, Largaespada DA, Sato A, Kaneda A, Zurawski SM, Doyle EL, Milatovich A, Francke U, Copeland NG, Jenkins NA, Zurawski G (1993) Structural comparison and chromosomal localization of the human and mouse IL-13 genes. J Immunol 150: 5436–5444.PubMedGoogle Scholar
  73. 73.
    Smirnov DV, Smirnova MG, Korobko VG, Frolova EI (1995) Tandem arrangement of human genes for interleukin-4 and interleukin-13: resemblance in their organization. Gene 155: 277–281.PubMedCrossRefGoogle Scholar
  74. 74.
    Punnonen J, Aversa G, Cocks BG, McKenzie ANJ, Menon S, Zurawski G, de Waal Malefyt R, de Vries JE (1993) Interleukin 13 induces Interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B-cells. Proc Natl Acad Sci USA 90: 3730–3734.PubMedCrossRefGoogle Scholar
  75. 75.
    Aversa G, Punnonen J, Cocks BG, de Waal Malefyt R, Vega FJ, Zurawski SM, Zurawski G, de Vries JE (1993) An interleukin 4 (IL-4) mutant protein inhibits both IL-4 or IL-13-induced human immunoglobulin G4 (IgG4) and IgE synthesis and B-cell proliferation: support for a common component shared by IL-4 and IL-13 receptors. J Exp Med 178: 2213–2218.PubMedCrossRefGoogle Scholar
  76. 76.
    Chaouchi N, Wallon C, Goujard C, Tertian G, Rudent A, Caput D, Ferrara P, Minty A, Vazquez A, Delfraissy J-F (1996) Interleukin-13 inhibits interleukin-2-induced proliferation and protects chronic lymphocytic leukemia B-cells from in vitro apoptosis. Blood 87: 1022–1029.PubMedGoogle Scholar
  77. 77.
    Sironi M, Sciacca FL, Matteucci C, Conni M, Vecchi A, Bemasconi S, Minty A, Caput D, Ferrara P, Colotta F, Mantovani A (1994) Regulation of endothelial and mesothelial cell function by interleukin-13: selective induction of vascular cell adhesion molecule-1 and amplification of interleukin-6 production. Blood 84: 1913–1921.PubMedGoogle Scholar
  78. 78.
    de Waal Malefyt R, Figdor CG, Huijbens R, Mohan-Peterson S, Bennett B, Culpepper J, Dang W, Zurawski G, de Vries JE (1993) Effects of IL-13 on phenotype, cytokine production, and cytotoxic function of human monocytes. Comparison with IL-4 and modulation by IFN-gamma or IL-10. J Immunol 151: 6370–6381.Google Scholar
  79. 79.
    Cash E, Minty A, Ferrara P, Caput D, Fradelizi D, Rott O (1994) Macrophage-inactivating IL-13 suppresses experimental autoimmune encephalomyelitis in rats. J Immunol 153: 4258–4267.PubMedGoogle Scholar
  80. 80.
    Marshall JD, Secrist H, De Kruyff RH, Wolf SF, Umetsu DT (1995) IL-12 inhibits the production of IL-4 and IL-10 in allergen-specific human CD4+ T lymphocytes. J Immunol 155: 111–117.PubMedGoogle Scholar
  81. 81.
    Manetti R, Gerosa F, Giudizi MG, Biagiotti R, Parronchi P, Piccinni MP, Sampognaro S, Maggi E, Romagnani S, Trinchieri G (1994) Interleukin 12 induces stable priming for interferon gamma (IFNgamma) production during differentiation of human T helper (Th) cells and transient IFN-gamma production in established Th2 cell clones. J Exp Med 179: 1273–1283.PubMedCrossRefGoogle Scholar
  82. 82.
    Yssel H, Fasler S, de Vries JE, de Waal Malefyt R (1994) IL-12 transiently induces IFN-gamma transcription and protein synthesis in human CD4+ allergen-specific Th2 T-cell clones. Int Immunol 6: 1091–1096.PubMedCrossRefGoogle Scholar
  83. 83.
    Parronchi P, De Carli M, Manetti R, Simonelli C, Sampognaro S, Piccinni MP, Macchia D, Maggi E, Del Prete G, Romagnani S (1992) IL-4 and IFN (alpha and gamma) exert opposite regulatory effects on the development of cytolytic potential by Th1 or Th2 human T-cell clones. J Immunol 149: 2977–2983.PubMedGoogle Scholar
  84. 84.
    Demeure CE, Wu CY, Shu U, Schneider PV, Heusser C, Yssel H, Delespesse G (1994) In vitro maturation of human neonatal CD4 T lymphocytes. II. Cytokines present at priming modulate the development of lymphokine production. J Immunol 152: 4775–4782.Google Scholar
  85. 85.
    de Waal Malefyt R, Abrams JS, Zurawski SM, Lecron J-C, Mohan-Peterson S, Sanjanwala B, Bennett B, Silver J, de Vries JE, Yssel H (1995) Differential regulation of IL-13 and IL-4 production by human CD8+ and CD4+ ThO, Thl and Th2 T-cell clones and EBV-transformed B-cells. Int Immunol 7: 1405–1416.CrossRefGoogle Scholar
  86. 86.
    Zurawski SM, Chomarat P, Djossou O, Bidaud C, McKenzie ANJ, Miossec P, Banchereau J, Zurawski G (1995) The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin-13 receptor. J Biol Chem 270:13, 869–13, 878.Google Scholar
  87. 87.
    Smerz-Bertling C, Duschl A (1995) Both interleukin 4 and interleukin 13 induce tyrosine phosphorylation of the 140-kDa subunit of the interleukin 4 receptor. J Biol Chem 270: 966–970.PubMedCrossRefGoogle Scholar
  88. 88.
    Hilton DJ, Zhang J-G, Metcalf D, Alexander WS, Nicola NA, Willson TA (1996) Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc Natl Acad Sci USA 93: 497–501.PubMedCrossRefGoogle Scholar
  89. 89.
    Russell SM, Keegan AD, Harada N, Nakamura Y, Noguchi M, Leland P, Friedmann MC, Miyajima A, Puri RK, Paul WE (1993) Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor. Science 262: 1880–1883.PubMedCrossRefGoogle Scholar
  90. 90.
    Kondo M, Takeshita T, Ishii N, Nakamura M, Watanabe S, Arai K, Sugamura K (1993) Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. Science 262: 1874–1877.PubMedCrossRefGoogle Scholar
  91. 91.
    Lin JX, Migone TS, Tsang M, Friedmann M, Weatherbee JA, Zhou L, Yamauchi A, Bloom ET, Mietz J, John S, Leonard WJ (1995) The role of shared receptor motifs and common Stat proteins in the generation of cytokine pleiotropy and redundancy by IL-2, IL-4, IL-7, IL-13, and IL-15. Immunity 2: 331–339.PubMedCrossRefGoogle Scholar
  92. 92.
    Matthews DJ, Clark PA, Herbert J, Morgan G, Armitage RJ, Kinnon C, Minty A, Grabstein KH, Caput D, Ferrara P, Callard R (1995) Function of the interleukin-2 (IL-2) receptor gamma-chain in biologic responses of X-linked severe combined immunodeficient B-cells to IL-2, IL-4, IL-13, and IL-15. Blood 85: 38–42.PubMedGoogle Scholar
  93. 93.
    He YW, Malek TR (1995) The IL-2 receptor gamma c chain does not function as a subunit shared by the IL-4 and IL-13 receptors. Implication for the structure of the IL-4 receptor. J Immunol 155: 9–12.PubMedGoogle Scholar
  94. 94.
    Punnonen J, de Vries JE (1994) IL-13 induces proliferation, Ig isotype switching, and Ig synthesis by immature human fetal B-cells. J Immunol 152: 1094–1102.PubMedGoogle Scholar
  95. 95.
    Zurawski G, De Vries JE (1994) Interleukin 13, an interleukin 4-like cytokine that acts on monocytes and B-cells, but not on T-cells. Immunol Today 15: 19–26. 19–26.Google Scholar
  96. 96.
    Taniguchi T (1995) Cytokine signaling through nonreceptor protein tyrosine kinases. Science 268: 251–255.PubMedCrossRefGoogle Scholar
  97. 97.
    Ihle JN, Witthuhn BA, Quelle FW, Yamamoto K, Thierfelder WE, Kreider B, Silvennoinen 0 (1994) Signaling by the cytokine receptor superfamily: JAKs and STATs. Trends Biochem Sci 19: 222–227.Google Scholar
  98. 98.
    Darnell JE Jr, Kerr IM, Stark GR (1994) Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264: 1415–1421.PubMedCrossRefGoogle Scholar
  99. 99.
    Quelle FW, Shimoda K, Thierfelder W, Fischer C, Kim A, Ruben SM, Cleveland JL, Pierce JH, Keegan AD, Nelms K (1995) Cloning of murine Stat6 and human Stat6, Stat proteins that are tyrosine phosphorylated in responses to IL-4 and IL-3 but are not required for mitogenesis. Mol Cell Biol 15: 3336–3343.PubMedGoogle Scholar
  100. 100.
    Izuhara K, Heike T, Otsuka T, Yamaoka K, Mayumi M, Imamura T, Niho Y, Harada N (1996) Signal transduction pathway of interleukin-4 and interleukin-13 in human B-cells derived from X-linked severe combined immunodeficiency patients. J Biol Chem 271: 619–622.PubMedCrossRefGoogle Scholar
  101. 101.
    Keegan AD, Johnston JA, Tortolani PJ, McReynolds LJ, Kinzer C, O’Shea JJ, Paul WE (1995) Similarities and differences in signal transduction by interleukin 4 and interleukin 13: analysis of Janus kinase activation. Proc Natl Acad Sci USA 92: 7681–7685.PubMedCrossRefGoogle Scholar
  102. 102.
    Fenghao X, Saxon A, Nguyen A, Ke Z, Diaz-Sanchez D, Nel A (1995) Interleukin 4 activates a signal transducer and activator of transcription (Stat) protein which interacts with an interferon-gamma activation site-like sequence upstream of the I epsilon exon in a human B-cell line. Evidence for the involvement of Janus kinase 3 and interleukin-4 Stat. J Clin Invest 96: 907–914.PubMedCrossRefGoogle Scholar
  103. 103.
    Murata T, Noguchi PD, Puri RK (1995) Receptors for interleukin (IL)-4 do not associate with the common gamma chain, and IL-4 induces the phosphorylation of JAK2 tyrosine kinase in human colon carcinoma cells. J Biol Chem 270: 30829–30836.PubMedCrossRefGoogle Scholar
  104. 104.
    Kaplan MH, Schindler U, Smiley ST, Grusby MJ (1996) Stat6 is required for mediating responses to IL-4 and for the development of Th2 cells. Immunity 4: 313–319.PubMedCrossRefGoogle Scholar
  105. 105.
    Kotanides H, Reich NC (1993) Requirement of tyrosine phosphorylation for rapid activation of a DNA binding factor by IL-4. Science 262: 1265–1267.PubMedCrossRefGoogle Scholar
  106. 106.
    Hou J, Schindler U, Henzel WJ, Ho TC, Brasseur M, McKnight SL (1994) An interleukin-4-induced transcription factor: IL-4 Stat. Science 265: 1701–1706.PubMedCrossRefGoogle Scholar
  107. 107.
    Coffman RL, Ohara J, Bond MW, Carty J, Zlotnik A, Paul WE (1986) B-cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B-cells. J Immunol 136: 4538–4541.PubMedGoogle Scholar
  108. 108.
    Tepper RI, Levinson DA, Stanger BZ, Campos-Torres J, Abbas AK, Leder P (1990) IL-4 induces allergic-like inflammatory disease and alters T-cell development in transgenic mice. Cell 62: 457–467.PubMedCrossRefGoogle Scholar
  109. 109.
    Finkelman FD, Katona IM, Urban JF Jr, Snapper CM, Ohara J, Paul WE (1986) Suppression of in vivo polyclonal IgE responses by monoclonal antibody to the lymphokine B-cell stimulatory factor 1. Proc Natl Acad Sci USA 83: 9675–9678.PubMedCrossRefGoogle Scholar
  110. 110.
    von der Weid T, Kopf M, Kohler G, Langhorne J (1994) The immune response to Plasmodium chabaudi malaria in interleukin-4-deficient mice. Eur J Immunol 24: 2285–2293.PubMedCrossRefGoogle Scholar
  111. 111.
    Noben-Trauth N, Kropf P, Muller I (1996) Susceptibility to Leishmania major infection in interleukin4-deficient mice. Science 271: 987–990.Google Scholar
  112. 112.
    Pene J, Rousset F, Briere F, Chretien I, Bonnefoy JY, Spits H, Yokota T, Arai N, Arai K, Banchereau J, De Vries JE (1988) IgE production by normal human lymphocytes is induced by interleukin 4 and suppressed by interferons gamma and alpha and prostaglandin E2. Proc Natl Acad Sci USA 85: 6880–6884.PubMedCrossRefGoogle Scholar
  113. 113.
    Pene J, Rousset F, Briere F, Chretien I, Paliard X, Banchereau J, Spits H, de Vries JE (1988) IgE production by normal human B-cells induced by alloreactive T-cell clones is mediated by IL-4 and suppressed by IFN-gamma. J Immunol 141: 1218–1224.PubMedGoogle Scholar
  114. 114.
    Vercelli D, Jabara HH, Arai K, Geha RS (1989) Induction of human IgE synthesis requires interleukin 4 and TB-cell interactions involving the T-cell receptor/CD3 complex and MHC class H antigens. J Exp Med 169: 1295–1307.PubMedCrossRefGoogle Scholar
  115. 115.
    Gascan H, Gauchat JF, Roncarolo MG, Yssel H, Spits H, de Vries JE (1991) Human B-cell clones can be induced to proliferate and to switch to IgE and IgG4 synthesis by interleukin 4 and a signal provided by activated CD4+ T-cell clones. J Exp Med 173: 747–750.PubMedCrossRefGoogle Scholar
  116. 116.
    Thyphronitis G, Tsokos GC, June CH, Levine AD, Finkelman FD (1989) IgE secretion by Epstein-Barr virus-infected purified human B lymphocytes is stimulated by interleukin 4 and suppressed by interferon gamma. Proc Natl Acad Sci USA 86: 5580–5584.PubMedCrossRefGoogle Scholar
  117. 117.
    Lundgren M, Persson U, Larsson P, Magnusson C, Smith CI, Hammarstrom L, Severinson E (1989) Interleukin 4 induces synthesis of IgE and IgG4 in human B-cells. Eur J Immunol 19: 1311–1315.PubMedCrossRefGoogle Scholar
  118. 118.
    Carballido JM, Schols D, Namikawa R, Zurawski S, Zurawski G, Roncarolo M-G, de Vries JE (1995) IL-4 induces human B-cell maturation and IgE synthesis in SCID-hu mice: inhibition of ongoing IgE production by in vivo treatment with an IL-4/1L-13 receptor antagonist. J Immunol 155: 4162–4170.PubMedGoogle Scholar
  119. 119.
    Michel FB, Bousquet J, Greillier P, Robinet-Levy M, Coulomb Y (1995) Comparison of cord blood immunoglobulin E concentrations and maternal allergy for the prediction of atopic diseases in infancy. J Allergy Clin Immunol 65: 422–430.Google Scholar
  120. 120.
    Magnusson CG (1988) Cord serum IgE in relation to family history and as predictor of atopic disease in early infancy. Allergy 43: 241–251.PubMedCrossRefGoogle Scholar
  121. 121.
    Punnonen J, de Vries JE (1993) Characterization of a novel CD2+ human thymic B-cell subset. J Immunol 151: 100–110.PubMedGoogle Scholar
  122. 122.
    Punnonen J, Aversa GG, Vandekerckhove B, Roncarolo M-G, de Vries JE (1992) Induction of isotype switching and Ig production by CDS+ and CD10+ human fetal B-cells. J Immunol 148: 3398–3404.PubMedGoogle Scholar
  123. 123.
    Punnonen J, Aversa G, de Vries JE (1993) Human pre-B cells differentiate into Ig-secreting plasma cells in the presence of interleukin-4 and activated CD4+ T-cells or their membranes. Blood 82: 2781–2789.PubMedGoogle Scholar
  124. 124.
    Lutzker S, Rothman P, Pollock R, Coffman R, Alt FW (1988) Mitogen-and IL-4-regulated expression of germ-line Ig gamma 2b transcripts: evidence for directed heavy chain class switching. Cell 53: 177–184.PubMedCrossRefGoogle Scholar
  125. 125.
    Berton MT, and Vitetta ES (1990) Interleukin 4 induces changes in the chromatin structure of the gl switch region in resting B-cells before switch recombination. J Exp Med 172: 375–388.PubMedCrossRefGoogle Scholar
  126. 126.
    Stavnezer J, Radcliffe G, Lin YC, Nietupski J, Berggren L, Sitia R, Severinson E (1988) Immunoglobulin heavy-chain switching may be directed by prior induction of transcripts from constant region genes. Proc Natl Acad Sci USA 85: 7704–7708.PubMedCrossRefGoogle Scholar
  127. 127.
    Rothman P, Chen YY, Lutzker S, Li SC, Stewart V, Coffman R, Alt FW (1990) Structure and expression of germ line immunoglobulin heavy-chain epsilon transcripts: interleukin-4 plus lipopolysaccharide-directed switching to C epsilon. Mol Cell Biol 10: 1672–1679.PubMedGoogle Scholar
  128. 128.
    Gauchat JF, Lebman DA, Coffman RL, Gascan H, de Vries JE (1990) Structure and expression of germline epsilon transcripts in human B-cells induced by interleukin 4 to switch to IgE production. J Exp Med 172: 463–473.PubMedCrossRefGoogle Scholar
  129. 129.
    Gauchat JF, Aversa G, Gascan H, de Vries JE (1992) Modulation of IL-4 induced germline epsilon RNA synthesis in human B-cells by tumor necrosis factor-alpha, anti-CD40 monoclonal antibodies or transforming growth factor-beta correlates with levels of IgE production. Int Immunol 4: 397–406.PubMedCrossRefGoogle Scholar
  130. 130.
    Thyphronitis G, Katona IM, Gause WC, Finkelman FD (1993) Germline and productive C epsilon gene expression during in vivo IgE responses. J Immunol 151: 4128–4136.PubMedGoogle Scholar
  131. 131.
    Ichiki T, Takahashi W, Watanabe T (1992) The effect of cytokines and mitogens on the induction of C epsilon germline transcripts in a human Burkitt lymphoma B-cell line. Int Immunol 4: 747–754.PubMedCrossRefGoogle Scholar
  132. 132.
    Jung S, Rajewsky K, Radbruch A (1993) Shutdown of class switch recombination by deletion of a switch region control element. Science 259: 984–987.PubMedCrossRefGoogle Scholar
  133. 133.
    Zhang J, Bottaro A, Li S, Stewart V, Alt FW (1993) A selective defect in IgG2b switching as a result of targeted mutation of the I gamma 2b promoter and exon. EMBO J 12: 3529–3537.PubMedGoogle Scholar
  134. 134.
    Lorenz M, Jung S, Radbruch A (1995) Switch transcripts in immunoglobulin class switching. Science 267: 1825–1828.PubMedCrossRefGoogle Scholar
  135. 135.
    Rothman P, Lutzker S, Cook W, Coffman R, Alt FW (1988) Mitogen plus interleukin 4 induction of C epsilon transcripts in B lymphoid cells. J Exp Med 168: 2385–2389.PubMedCrossRefGoogle Scholar
  136. 136.
    Gauchat JF, Gascan H, de Waal Malefyt R, de Vries JE (1992) Regulation of germ-line epsilon transcription and induction of epsilon switching in cloned EBV-transformed and malignant human B-cell lines by cytokines and CD4+ T-cells. J Immunol 148: 2291–2299.PubMedGoogle Scholar
  137. 137.
    Jabara HH, Schneider LC, Shapira SK, Alfieri C, Moody CT, Kieff E, Geha RS, Vercelli D (1990) Induction of germ-line and mature C epsilon transcripts in human B-cells stimulated with rIL-4 and EBV. J Immunol 145: 3468–3473.PubMedGoogle Scholar
  138. 138.
    Punnonen J, Cocks BG, de Vries JE (1995) IL-4 induces germline IgE heavy chain gene transcription in human fetal pre-B cells: evidence for differential expression of functional IL-4 and IL-13 receptors during B-cell ontogeny. J Immunol 155: 4248–4254.PubMedGoogle Scholar
  139. 139.
    Cocks BG, Gauchat J-F, Aversa G, Punnonen J, Jehn C-D, Zavodny P, de Vries JE. IL-4 and IL-13induced germline e promoter activity in human B-cells is transiently inhibited by IFN-y and IFN-a. (submitted)Google Scholar
  140. 140.
    Pene J, Chretien I, Rousset F, Briere F, Bonnefoy JY, de Vries JE (1989) Modulation of IL-4-induced human IgE production in vitro by IFN-gamma and IL-5: the role of soluble CD23 (s-CD23). J Cell Biochem 39: 253–264.PubMedCrossRefGoogle Scholar
  141. 141.
    Souillet G, Rousset F, de Vries JE (1989) Alpha-interferon treatment of patient with hyper IgE syndrome. Lancet 1: 1384.PubMedCrossRefGoogle Scholar
  142. 142.
    Finkelman FD, Svetic A, Gresser I, Snapper C, Holmes J, Trotta PP, Katona IM, Gause WC (1991) Regulation by interferon alpha of immunoglobulin isotype selection and lymphokine production in mice. J Exp Med 174: 1179–1188.PubMedCrossRefGoogle Scholar
  143. 143.
    King CL, Gatlin JI, Malech HL, Abramson SL, Nutman TB (1989) Regulation of immunoglobulin production in hyperimmunoglobulin E recurrent-infection syndrome by interferon gamma. Proc Natl Acad Sci USA 86:10, 085–10, 089.Google Scholar
  144. 144.
    Wang ZE, Reiner SL, Zheng S, Dalton DK, Locksley RM (1994) CD4* effector cells default to the Th2 pathway in interferon gamma-deficient mice infected with Leishmania major. J Exp Med 179: 1367–1371.PubMedCrossRefGoogle Scholar
  145. 145.
    Xu L, Rothman P (1994) IFN-gamma represses epsilon germline transcription and subsequently down-regulates switch recombination to epsilon. Int Immunol 6: 515–521.PubMedCrossRefGoogle Scholar
  146. 146.
    Kehrl JH, Taylor A, Kim SJ, Fauci AS (1991) Transforming growth factor-beta is a potent negative regulator of human lymphocytes. Ann NY Acad Sci 628: 345–353.PubMedCrossRefGoogle Scholar
  147. 147.
    Wahl SM (1992) Transforming growth factor beta (TGF-beta) in inflammation: a cause and a cure. J Clin Immunol 12: 61–74.PubMedCrossRefGoogle Scholar
  148. 148.
    Van Vlasselaer P, Punnonen J, de Vries JE (1992) Transforming growth factor (3 directs IgA switching in human B-cells. J Immunol 148: 2062–2067.PubMedGoogle Scholar
  149. 149.
    Stavnezer J (1995) Regulation of antibody production and class switching by TGF-beta. J Immunol 155: 1647–1651.PubMedGoogle Scholar
  150. 150.
    Defrance T, Vanbervliet B, Briere F, Durand I, Rousset F, Banchereau J (1992) Interleukin 10 and transforming growth factor beta cooperate to induce anti-CD40-activated naive human B-cells to secrete immunoglobulin A. J Exp Med 175: 671–682.Google Scholar
  151. 151.
    Islam KB, Nilsson L, Sideras P, Hammarstrom L, Smith CI (1991) TGF-beta 1 induces germ-line transcripts of both IgA subclasses in human B lymphocytes. Int Immunol 3: 1099–1106.PubMedCrossRefGoogle Scholar
  152. 152.
    Wu CY, Brinkmann V, Cox D, Heusser C, Delespesse G (1992) Modulation of human IgE synthesis by transforming growth factor-beta. Clin Immunol Immunopathol 62: 277–284.PubMedCrossRefGoogle Scholar
  153. 153.
    Rehmann JA, Le Bien TW (1994) Transforming growth factor-beta regulates normal human pre-B-cell differentiation. Int Immunol 6: 315–322.PubMedCrossRefGoogle Scholar
  154. 154.
    Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B (1975) An endotoxin-induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA 72: 3666–3670.PubMedCrossRefGoogle Scholar
  155. 155.
    Aggarwal BB, Kohr WJ, Hass PE, Moffat B, Spencer SA, Henxel WJ, Bringman TS, Nedwin GE, Goeddel DV, Harkins RN (1985) Human tumor necrosis factor. J Biol Chem 260: 2345–2354.PubMedGoogle Scholar
  156. 156.
    Ziegler EJ (1988) Tumor necrosis factor in humans. N Engl J Med 318: 1533–1534.PubMedCrossRefGoogle Scholar
  157. 157.
    Pennica D, Nedwin GE, Hayflick JS, Seeburg PH, Derynck R, Palladino MA, Kohr WJ, Aggarwal BB, Goeddel DV (1984) Human tumor necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 312: 724–729.PubMedCrossRefGoogle Scholar
  158. 158.
    Aggarwal BB, Eessalu TE, Hass PE (1985) Characterization of receptors for human tumor necrosis factor and their regulation by gamma-interferon. Nature 318: 665–667.PubMedCrossRefGoogle Scholar
  159. 159.
    Kehrl JH, Miller A, Fauci AS (1987) Effect of tumor necrosis factor alpha on mitogen-activated human B-cells. J Exp Med 166: 786–791.PubMedCrossRefGoogle Scholar
  160. 160.
    Yokota S, Geppert TD, Lipsky PE (1988) Enhancement of antigen-and mitogen-induced human T lymphocyte proliferation by tumor necrosis factor-alpha. J Immunol 140: 531–536.PubMedGoogle Scholar
  161. 161.
    Janssen O, Kabelitz D (1988) Tumor necrosis factor selectively inhibits activation of human B-cells by Epstein-Barr virus. J Immunol 140: 125–130.PubMedGoogle Scholar
  162. 162.
    Kehrl JH, Alvarez-Mon M, Delsing GA, Fauci AS (1987) Lymphotoxin is an important T-cell-derived growth factor for human B-cells. Science 238: 1144–1146.PubMedCrossRefGoogle Scholar
  163. 163.
    Boussiotis VA, Nadler LM, Strominger JL, Goldfeld AE (1994) Tumor necrosis factor alpha is an autocrine growth factor for normal human B-cells. Proc Natl Acad Sci USA 91: 7007–7011.PubMedCrossRefGoogle Scholar
  164. 164.
    Worm M, Geha RS (1994) CD40 ligation induces lymphotoxin alpha gene expression in human B-cells. Int Immunol 6: 1883–1890.PubMedCrossRefGoogle Scholar
  165. 165.
    Aversa G, Punnonen J, de Vries JE (1993) The 26-kD transmembrane form of tumor necrosis factor alpha on activated CD4* T-cell clones provides a costimulatory signal for human B-cell activation. J Exp Med 177: 1575–1585.PubMedCrossRefGoogle Scholar
  166. 166.
    Macchia D, Almerigogna F, Parronchi P, Ravina A, Maggi E, Romagnani S (1993) Membrane tumour necrosis factor-alpha is involved in the polyclonal B-cell activation induced by HIV-infected human T-cells. Nature 363: 461 166.Google Scholar
  167. 167.
    Muraguchi A, Kehrl JH, Longo DL, Volkman DJ, Smith KA, Fauci AS (1985) Interleukin 2 receptors on human B-cells. Implications for the role of interleukin 2 in human B-cell function. J Exp Med 161: 181–197.PubMedCrossRefGoogle Scholar
  168. 168.
    Karasuyama H, Rolink A, Melchers F (1988) Recombinant interleukin 2 or 5, but not 3 or 4, induces maturation of resting mouse B lymphocytes and propagates proliferation of activated B-cell blasts. J Exp Med 167: 1377–1390.PubMedCrossRefGoogle Scholar
  169. 169.
    Punnonen J Eskola J (1987) Recombinant interleukin 2 induces proliferation and differentiation of human B lymphocytes. Acta Path Microbiol Immunol Scand 95:167–172.Google Scholar
  170. 170.
    Schorle H, Holtschke T, Hunig T, Schimpl A, Horak I (1991) Development and function of T-cells in mice rendered interleukin-2 deficient by gene targeting. Nature 352: 621–624.PubMedCrossRefGoogle Scholar
  171. 171.
    Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, Horak I (1993) Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75: 253–261.PubMedCrossRefGoogle Scholar
  172. 172.
    Armitage RJ, Macduff BM, Eisenman J, Paxton R, Grabstein KH (1995) IL-15 has stimulatory activity for the induction of B-cell proliferation and differentiation. J Immunol 154: 483–490.PubMedGoogle Scholar
  173. 173.
    Nonoyama S, Farrington ML, Ochs HD (1994) Effect of IL-2 on immunoglobulin production by antiCD40-activated human B-cells: synergistic effect with IL-10 and antagonistic effect with IL-4. Clin Immunol Immunopathol 72: 373–379.PubMedCrossRefGoogle Scholar
  174. 174.
    Maggi E, Del Prete GF, Parronchi P, Tiri A, Macchia D, Biswas P, Simonelli C, Ricci M, Romagnani S (1989) Role for T-cells, IL-2 and IL-6 in the IL-4-dependent in vitro human IgE synthesis. Immunology 68: 300–306.PubMedGoogle Scholar
  175. 175.
    Miyajima H, Hirano T, Hirose S, Karasuyama H, Okumura K, Ovary Z (1991) Suppression by IL-2 of IgE production by B-cells stimulated by IL-4. J Immunol 146: 457–462.Google Scholar
  176. 176.
    Nakanishi K, Yoshimoto T, Chu CC, Matsumoto H, Hase K, Nagai N, Tanaka T, Miyasaka M, Paul WE, Shinka S (1995) IL-2 inhibits IL-4-dependent IgE and IgGI production in vitro and in vivo. Int Immunol 7: 259–268.PubMedCrossRefGoogle Scholar
  177. 177.
    Spiegelberg HL, Falkoff RJ, O’Connor RD, Beck L (1991) Interleukin-2 inhibits the interleukin-4induced human IgE and IgG4 secretion in vivo. Clin Exp Immunol 84: 400–405.PubMedGoogle Scholar
  178. 178.
    Punnonen J, Punnonen K, Jansen CT, Kalimo K (1993) Interferon(IFN)-a, IFN-y, interleukin(IL)-2, and arachidonic acid metabolites modulate IL-4 induced IgE synthesis similarly in healthy individuals and atopic dermatitis patients. Allergy 48: 189–195.PubMedCrossRefGoogle Scholar
  179. 179.
    Egan RW, Athwahl D, Chou CC, Emtage S, Jehn CH, Kung TI’, Mauser PJ, Murgolo NJ, Bodmer MW (1995) Inhibition of pulmonary eosinophilia and hyperreactivity by antibodies to interleukin-5. Int Arch Allergy Immunol 107: 321–322.PubMedCrossRefGoogle Scholar
  180. 180.
    Loughnan MS, Nossal GJ (1989) Interleukins 4 and 5 control expression of IL-2 receptor on murine B-cells through independent induction of its two chains. Nature 340: 76–79.PubMedCrossRefGoogle Scholar
  181. 181.
    Kinashi T, Harada N, Severinson E, Tanabe T, Sideras P, Konishi M, Azuma C, Tominaga A, Bergstedt-Lindqvist S, Takahashi M, Matsuda F, Yaoita Y, Takatsu K, Honjo T (1986) Cloning of complementary DNA encoding T-cell replacing factor and identity with B-cell growth factor II. Nature 324: 70–76.PubMedCrossRefGoogle Scholar
  182. 182.
    Alderson MR, Pike BL, Harada N, Tominaga A, Takatsu K, Nossal GJ (1987) Recombinant T-cell replacing factor (interleukin 5) acts with antigen to promote the growth and differentiation of single hapten-specific B lymphocytes. J Immunol 139: 2656–2660.PubMedGoogle Scholar
  183. 183.
    Azuma C, Tanabe T, Konishi T, Noma T, Matsuda F, Yaoita Y, Takatsu K, Hammarström L, Smith CIE, Severinson E, Honjo T (1986) Cloning of cDNA for human T-cell replacing factor (interleukin-5) and comparison with the murine homologue. Nucleic Acids Res 14: 9149–9158.PubMedCrossRefGoogle Scholar
  184. 184.
    Glutterbuck E, Shields JG, Gordon J, Smith SH, Boyd A, Callard RE, Campbell HD, Young IG, Sanderson CJ (1987) Recombinant human interleukin 5 is an eosinophil differentiation factor but has no activity in standard human B-cell growth factor assays. Eur J Immunol 17: 1743–1750.CrossRefGoogle Scholar
  185. 185.
    Pene J, Rousset F, Briere F, Chretien I, Wideman J, Bonnefoy JY, de Vries JE (1988) Interleukin 5 enhances interleukin 4-induced IgE production by normal human B-cells. The role of soluble CD23 anti-gen. Eur J Immunol 18: 929–935.PubMedCrossRefGoogle Scholar
  186. 186.
    Huston MH, Moore JP, Mettes HJ, Tavana G, Huston D (1996) Human B-cells express IL-5 receptor messenger ribonucleic acid and respond to IL-5 with enhanced IgM production after mitogenic stimulation with Moraxella catarrhalis. J Immunol 156: 1392–1401.PubMedGoogle Scholar
  187. 187.
    Hirano T, Yasukawa K, Harada H, Taga T, Watanabe Y, Matsuda T, Kashiwamura S, Nakajima K, Koyama K, Iwamatsu A, Tsunasawa S, Sakiyama F, Matsui H, Takahara Y, Taniguchi T, Kishimoto T (1986) Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 324: 73–76.Google Scholar
  188. 188.
    Punnonen J, de Waal Malefyt R, van Vlasselar P, Gauchat J-F, de Vries JE (1993) IL-10 and viral IL-10 prevent IL-4-induced IgE synthesis by inhibiting the accessory cell function of monocytes. J Immunol 151: 1280–1289.PubMedGoogle Scholar
  189. 189.
    Vercelli D, Jabara HH, Arai K, Yokota T, Geha RS (1989) Endogenous interleukin 6 plays an obligatory role in interleukin 4-dependent human IgE synthesis. Eur J Immunol 19: 1419–1424.PubMedCrossRefGoogle Scholar
  190. 190.
    Ramsay AJ, Husband AJ, Ramshaw IA, Bao S, Matthaei KI, Koehler G, Kopf M (1994) The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 264: 561–563.PubMedCrossRefGoogle Scholar
  191. 191.
    Lindley I, Aschauer H, Seifert JM, Lam C, Brunowsky W, Kownatzki E, Thelen M, Peveri P, Dewald B, von Tscharner V, Walz A, Baggiolini M (1988) Synthesis and expression in Escherichia coli of the gene encoding monocyte-derived neutrophil-activating factor: biological equivalence between natural and recombinant neutrophil-activating factor. Proc Natl Acad Sci USA 85: 9199–9203.PubMedCrossRefGoogle Scholar
  192. 192.
    Larsen CG, Anderson AO, Appella E, Oppenheim JJ, Matsushima K (1989) The neutrophil-activating protein (NAP-1) is also chemotactic for T-lymphocytes. Science 243: 1464–1466.PubMedCrossRefGoogle Scholar
  193. 193.
    Dahinden CA, Kurimoto Y, De Weck AL, Lindley I, Dewald B, Baggiolini M (1989) The neutrophilactivating peptide NAF/NAP-1 induces histamine and leukotriene release by interleukin 3-primed basophils. J Exp Med 170: 1787–1792.PubMedCrossRefGoogle Scholar
  194. 194.
    Gimbrone MA Jr, Obin MS, Brock AF, Luis EA, Hass PE, Hebert CA, Yip YK, Leung DW, Lowe DG, Kohr WJ, Darbonne WC, Bechtol KB, Baker JB (1989) Endothelial interleukin-8: a novel inhibitor of leukocyte-endothelial interactions. Science 246: 1601–1603.PubMedCrossRefGoogle Scholar
  195. 195.
    Luscinskas FW, Kiely JM, Ding H, Obin MS, Hebert CA, Baker JB, Gimbrone MA Jr (1992) In vitro inhibitory effect of IL-8 and other chemoattractants on neutrophil-endothelial adhesive interactions. J Immunol 149: 2163–2171.PubMedGoogle Scholar
  196. 196.
    Kimata H, Yoshida A, Ishioka C, Lindley I, Mikawa H (1992) Interleukin 8 (IL-8) selectively inhibits immunoglobulin E production induced by IL-4 in human B-cells. J Exp Med 176: 1227–1231.Google Scholar
  197. 197.
    Kimata H, Lindley I, Furusho K (1995) Selective inhibition of spontaneous IgE and IgG4 production by interleukin-8 in atopic patients. Blood 85: 3191–3198.PubMedGoogle Scholar
  198. 198.
    Kimata H, Lindley I (1994) Detection of plasma interleukin-8 in atopic dermatitis. Arch Dis Child 70: 119–122.PubMedCrossRefGoogle Scholar
  199. 199.
    Moore KW, O’Garra A, de Waal Malefyt R, Vieira P, Mosmann TR (1993) Interleukm-10. Annu Rev Immunol 11: 165–190.CrossRefGoogle Scholar
  200. 200.
    de Waal Malefyt R, Abrams J, Bennett B, Figdor CG, De Vries JE (1991) Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 174: 1209–1220.CrossRefGoogle Scholar
  201. 201.
    Fiorentino DF, Zlotnik A, Mosmann TR, Howard M, O’Garra A (1991) IL-10 inhibits cytokine production by activated macrophages. J Immunol 147: 3815–3824.PubMedGoogle Scholar
  202. 202.
    de Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, te Velde A, Figdor C, Johnson K, Kastelein R, Yssel H, de Vries JE (1991) Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T-cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class H major histocompatibility complex expression. J Exp Med 174: 915–924.CrossRefGoogle Scholar
  203. 203.
    Ding L, Shevach EM (1992) IL-10 inhibits mitogen-induced T-cell proliferation by selectively inhibiting macrophage costimulatory function. J Immunol 148: 3133–3141.PubMedGoogle Scholar
  204. 204.
    Taga K, Tosato G (1992) IL-10 inhibits human T-cell proliferation and IL-2 production. J Immunol 148: 1143–1152.PubMedGoogle Scholar
  205. 205.
    Willems F, Marchant A, Delville JP, Gerard C, Delvaux A, Velu T, de Boer M, Goldman M (1994) Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes. Eur J Immunol 24: 1007–1009.PubMedCrossRefGoogle Scholar
  206. 206.
    Buelens C, Willems F, Delvaux A, Pierard G, Delville JP, Velu T, Goldman M (1995) Interleukin-10 differentially regulates B7–1 (CD80) and B7–2 (CD86) expression on human peripheral blood dendritic cells. Eur J Immunol 25: 2668–2672.PubMedCrossRefGoogle Scholar
  207. 207.
    Moore KW, Vieira P, Fiorentino DF, Trounstine ML, Khan TA, Mosmann TR (1990) Homology of cytokine synthesis inhibitory factor (IL-10) to the Epstein-Barr virus gene BCRFI. Science 248: 1230–1234.PubMedCrossRefGoogle Scholar
  208. 208.
    Vieira P, de Waal-Malefyt R, Dang MN, Johnson KE, Kastelein R, Fiorentino DF, De Vries JE, Roncarolo MG, Mosmann TR, Moore KW (1991) Isolation and expression of human cytokine synthesis inhibitory factor cDNA clones: homology to Epstein-Barr virus open reading frame BCRFI. Proc Natl Acad Sci USA 88: 1172–1176.PubMedCrossRefGoogle Scholar
  209. 209.
    Bober LA, Grace MJ, Pugliese-Sivo C, Waters TA, Sullivan LM, Narula SK (1994) Human IL-10 reduces the number of IL-4-induced IgE B-cells in cultures of atopic mononuclear cells. Int. Arch. Allergy Immunol 105: 26–31.Google Scholar
  210. 210.
    Jabara HH, Vercelli D (1994) Engagement of CD14 on monocytes inhibits the synthesis of human Igs, including IgE. J Immunol 153: 972–978.PubMedGoogle Scholar
  211. 211.
    Rousset F, Garcia E, Defrance T, Peronne C, Vezzio N, Hsu DH, Kastelein R, Moore KW, Banchereau J (1992) Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc Natl Acad Sci USA 89: 1890–1893.PubMedCrossRefGoogle Scholar
  212. 212.
    Go NF, Castle BE, Barrett R, Kastelein R, Dang W, Mosmann TR, Moore KW, Howard M (1990) Interleukin 10, a novel B-cell stimulatory factor: unresponsiveness of X chromosome-linked immunodeficiency B-cells. J Exp Med 172: 1625–1631.Google Scholar
  213. 213.
    Trinchieri G (1995) Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 13: 251–276.PubMedCrossRefGoogle Scholar
  214. 214.
    Kiniwa M, Gately M, Gubler U, Chizzonite R, Fargeas C, Delespesse G (1992) Recombinant interleukin-12 suppresses the synthesis of immunoglobulin E by interleukin-4 stimulated human lymphocytes. J Clin Invest 90: 262–266.Google Scholar
  215. 215.
    Morris SC, Madden KB, Adamovicz JJ, Gause WC, Hubbard BR, Gately MK, Finkelman FD (1994) Effects of IL-12 on in vivo cytokine gene expression and Ig isotype selection. J Immunol 152: 1047–1056.Google Scholar
  216. 216.
    Germann T, Bongartz M, Dlugonska H, Hess H, Schmitt E, Kolbe L, Kolsch E, Podlaski FJ, Gately MK, Rude E (1995) Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo. Eur J Immunol 25: 823–829.PubMedCrossRefGoogle Scholar
  217. 217.
    Kruse N, Tony HP, Sebald W (1992) Conversion of human interleukin-4 into a high affinity antagonist by a single amino acid replacement. EMBO J 11: 3237–3244.PubMedGoogle Scholar
  218. 218.
    Tony HP, Shen BJ, Reusch P, Sebald W (1994) Design of human interleukin-4 antagonists inhibiting interleukin-4-dependent and interleukin-13-dependent responses in T-cells and B-cells with high efficiency. Eur J Biochem 225: 659–665.PubMedCrossRefGoogle Scholar
  219. 219.
    Carballido JM, Aversa G, Schols D, Punnonen J, de Vries JE (1995) Inhibition of human IgE synthesis in vitro and in SCID-hu mice by an interleukin-4 receptor antagonist. Int Arch Allergy Immunol 107: 304–307.PubMedCrossRefGoogle Scholar
  220. 220.
    Sato TA, Widmer MB, Finkelman FD, Madani H, Jacobs CA, Grabstein KH, Maliszewski CR (1993) Recombinant soluble murine IL-4 receptor can inhibit or enhance IgE responses in vivo. J Immunol 150: 2717–2723.PubMedGoogle Scholar
  221. 221.
    Atamas SP, Choi J, Yurovsky VV, White B (1996) An alternative splice variant of human IL-4, IL-4delta2, inhibits IL-4-stimulated T-cell proliferation. J Immunol 156: 435–441.PubMedGoogle Scholar
  222. 222.
    Haba S, Nisonoff A (1994) Role of antibody and T-cells in the long-term inhibition of IgE synthesis. Proc Natl Acad Sci USA 91: 604–608.PubMedCrossRefGoogle Scholar
  223. 223.
    Amiri P, Haak-Frendscho M, Robbins K, McKerrow JH, Stewart T, Jardieu P (1994) Anti-immunoglobulin E treatment decreases worm burden and egg production in Schistosoma mansoni-infected normal and interferon gamma knockout mice. J Exp Med 180: 43–51.PubMedCrossRefGoogle Scholar
  224. 224.
    Presta LG, Lahr SJ, Shields RL, Porter JP, Gorman CM, Fendly BM, Jardieu PM (1993) Humanization of an antibody directed against IgE. J Immunol 151: 2623–2632.PubMedGoogle Scholar
  225. 225.
    Jardieu P (1995) Anti-IgE therapy. Curr Opin Immunol 7: 779–782.PubMedCrossRefGoogle Scholar
  226. 226.
    Cocks BG, Chang C-CJ, Carballido JM, Yssel H, de Vries JE, Aversa G (1995) A novel receptor involved in T-cell activation. Nature 376: 260–263.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1998

Authors and Affiliations

  • Juha Punnonen
  • Jan E. de Vries

There are no affiliations available

Personalised recommendations